Insulet Corp. (PODD) Interest Coverage Ratio: 5.94x
The interest coverage ratio for Insulet Corp. (PODD) is 5.94x as of Thursday, June 25, 2026.
PODD Interest Coverage Ratio Metrics
INTEREST COVERAGE RATIO
5.94x
PODD Competitors' Interest Coverage Ratio
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Insulet Corp. (PODD) | $10.31B | 5.94x | N/A | N/A | N/A |
| Walgreens Boots Alliance, Inc. (WBA)vs › | $10.37B | -29.20x | 3.03x | 3.75x | 5.52x |
| Baxter International Inc. (BAX)vs › | $10.87B | -1.06x | 0.71x | 2.65x | 6.89x |
| Charles River Laboratories International, Inc. (CRL)vs › | $9.73B | 4.74x | 3.27x | 5.51x | 5.84x |
| Henry Schein, Inc. (HSIC)vs › | $9.38B | 5.05x | 5.30x | 10.04x | 14.14x |
| Revvity, Inc. (RVTY)vs › | $11.78B | 3.87x | 4.06x | 4.92x | 8.88x |
| Align Technology, Inc. (ALGN)vs › | $12.24B | N/A | 67.41x | 66.08x | 407.22x |
| Solventum Corporation (SOLV)vs › | $13.01B | 6.29x | 4.55x | 4.55x | 4.55x |
| Bio-Rad Laboratories, Inc. (BIO)vs › | $7.57B | 5.52x | 5.51x | 7.63x | 62.06x |
| Oscar Health, Inc. (OSCR)vs › | $7.56B | -22.52x | 2.41x | 2.41x | 2.41x |
Financial Health Indicators
Interest Coverage
5.9x
Debt/Equity
0.69
Current Ratio
2.78
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
- < 1.5x: EBIT is less than 1.5 times interest expense
- 1.5x - 3x: EBIT is between 1.5 and 3 times interest expense
- 3x - 5x: EBIT is between 3 and 5 times interest expense
- > 5x: EBIT is more than 5 times interest expense
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Insulet Corp. Interest Coverage Ratio Formula & Definition
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Insulet Corp. Interest Coverage Ratio FAQ
- What is the interest coverage ratio for Insulet Corp. (PODD)?
- The interest coverage ratio for PODD stock is 5.94x.
About Insulet Corp.
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes a proprietary AID algorithm embedded in the pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless Bluetooth communication; Omnipod DASH insulin management system that features a Bluetooth enabled pod that is controlled by a smartphone-like personal diabetes manager with a color touch screen user interface; and the Omnipod Insulin Management System. It also provides pods for Amgen for use in the Neulasta Onpro kit, which is a delivery system to help reduce the risk of infection after intense chemotherapy. The company sells its products to end-users through the pharmacy channel; and independent distributors. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Ashley A. McEvoy